ANGIODYNAMICS INC (ANGO)
About ANGIODYNAMICS INC
AngioDynamics Inc is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing, and selling products and technologies which aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. The company's execution plan is built on R&D, clinical and regulatory pathway expansion, and customer-centric sales performance. The company's product offerings fall within two segments, Med Tech and Med Device. Geographically operates in the USA and Other countries, maximum revenue from the USA.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $292.5M
- Net income
- -$34.0M
- Total assets
- $280.1M
- Market cap
- $561.7M
- Gross margin
- 54.6%
- Operating margin
- -12.5%
- Net margin
- -11.5%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $320.2M
- Cost of revenue
- $145.3M
- Gross profit
- $174.9M
- Operating expenses
- $214.8M
- Operating income
- -$39.9M
- Income tax
- $442.0K
- Net income
- -$36.7M
- EPS (basic)
- $-0.88
- EPS (diluted)
- $-0.88
Balance sheet
- Total assets
- $267.2M
- Current assets
- $163.4M
- Total liabilities
- $96.3M
- Current liabilities
- $74.7M
- Shareholders’ equity
- $170.8M
Cash flow
- Operating cash flow
- $3.1M
- Investing cash flow
- -$5.9M
- Financing cash flow
- $564.0K
- Net cash flow
- -$2.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $561.7M
- EPS (diluted)
- $-0.88
- Shares outstanding
- 35.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 27, 2004
Angiodynamics Inc (ANGO) Stock Price
- Reported a net loss of $34.0M in FY2025.
- Revenue grew 1% from FY2022 to FY2026.
- Gross margin of 54.6%, net margin -11.5%.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review ANGIODYNAMICS INC.
Write a review
News about ANGIODYNAMICS INC
News & sentiment via Polygon.io
Angiodynamics Inc: frequently asked questions
Is Angiodynamics Inc an American company?
Angiodynamics Inc is a US-based company headquartered in Latham, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Angiodynamics Inc headquartered?
Angiodynamics Inc is headquartered in Latham, New York, United States.
Is Angiodynamics Inc publicly traded?
Yes — Angiodynamics Inc is a publicly traded company. Its stock trades under the ticker symbol ANGO on the NASDAQ.
What does Angiodynamics Inc do?
Angiodynamics Inc is an American Medical Devices company in the Health & Beauty sector.
